布拉氏酵母菌联合香砂枳术丸治疗功能性消化不良临床疗效观察

来源 :中国微生态学杂志 | 被引量 : 0次 | 上传用户:jianjie12321
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨布拉氏酵母菌联合香砂枳术丸治疗功能性消化不良(FD)的临床疗效。方法 258例FD患者随机分为A组、B组和C组,各86例,A组给予香砂枳术丸一次1袋,一日2次口服;B组给予布拉氏酵母菌散剂1.0g/次,一日2次口服;C组(A组+B组),4周为一疗程。结果 C组临床总有效率均明显优于A组与B组(P<0.01,P<0.05),差异有显著性。3组临床症状积分均比治疗前降低;治疗后C组与A组、B组比较(P均<0.01),差异有显著性。复发率比较:C组明显低于A组、B组(P<0.01,P<0.05),差异有显著性。治疗过程中未见明显不良反应。结论布拉氏酵母菌联合香砂枳术丸可明显提高FD的临床疗效,降低复发率。 Objective To investigate the clinical efficacy of B yeast combined with Xiangsha Zhizhu Pills in the treatment of functional dyspepsia (FD). Methods A total of 258 patients with FD were randomly divided into group A, group B and group C, with 86 cases in each group. Group A received Xiangsha Zhizhu Pills once a day for 2 times a day. Group B received 1.03g / Times, 2 times a day orally; C group (A + B group), 4 weeks for a course of treatment. Results The total clinical effective rate in group C was significantly better than that in group A and group B (P <0.01, P <0.05), the difference was significant. The scores of clinical symptom in 3 groups were all lower than those before treatment. There was significant difference between C group and A group and B group after treatment (P <0.01). Relapse rate comparison: C group was significantly lower than the A group, B group (P <0.01, P <0.05), the difference was significant. No obvious adverse reactions during treatment. Conclusion The combination of Brachyevilla and Xiangsha Zhizhu Pill can significantly improve the clinical efficacy and reduce the recurrence rate of FD.
其他文献
1886年2月13日,汤玛斯·埃肯斯(Thomas Eakins,1844-1916)离开了费城艺术学院(Pennsylvania Academy of the Fine Arts)。这所男女合校的艺术院校一直坚持男模特必须使用束腰布——汤玛斯·埃肯斯原来也遵循这一原则——直到有一天,他以解释人体的生理细节为由亲自扯下了这块布。在此前几年,已经有学生和家长抱怨说,他对人体的兴趣已经远远超过了艺术的